ELASTAGEN

elastagen-logo

Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen has developed a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagen’s platform technology has... potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagen’s operations have expanded from its Australian base to include production in Europe and clinical operations in the UK.

#People #Financial #Website #More

ELASTAGEN

Social Links:

Industry:
Biotechnology Clinical Trials Medical Medical Device

Founded:
2003-01-01

Address:
Sydney, New South Wales, Australia

Country:
Australia

Website Url:
http://www.elastagen.com

Total Employee:
1+

Status:
Active

Contact:
+61 (0)2 9209 4054

Email Addresses:
[email protected]

Total Funding:
15.12 M USD

Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Dreamscape Networks



Current Advisors List

stephen-thompson_image

Stephen Thompson Member of the Board of Directors @ Elastagen
Board_member

robert-daniels_image

Robert Daniels Member of the Board of Directors @ Elastagen
Board_member

sangwoo-lee_image

Sangwoo Lee Member of the Board of Directors @ Elastagen
Board_member

brigitte-smith_image

Brigitte Smith Member of the Board of Directors @ Elastagen
Board_member
2015-01-01

tony-weiss_image

Tony Weiss Scientific Advisor @ Elastagen
Advisor
2008-01-01

xavier-yon_image

Xavier Yon Member of the Board of Directors @ Elastagen
Board_member
2011-01-01

marc-gleeson_image

Marc Gleeson Member of the Board of Directors @ Elastagen
Board_member
2016-04-01

Current Employees Featured

emma-mcgilly_image

Emma McGilly
Emma McGilly Office Manager @ Elastagen
Office Manager
2012-10-01

tony-weiss_image

Tony Weiss
Tony Weiss Founder @ Elastagen
Founder
2003-01-01

Founder


tony-weiss_image

Tony Weiss

Investors List

medical-devices-fund_image

Medical Devices Fund

Medical Devices Fund investment in Grant - Elastagen

korea-investment-partners_image

Korea Investment Partners

Korea Investment Partners investment in Series B - Elastagen

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Series B - Elastagen

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series B - Elastagen

brandon-capital-partners_image

Brandon Capital Partners

Brandon Capital Partners investment in Series B - Elastagen

atp-innovations_image

Cicada Innovations

Cicada Innovations investment in Series B - Elastagen

amorepacific-ventures_image

AMOREPACIFIC Ventures

AMOREPACIFIC Ventures investment in Series B - Elastagen

atp-innovations_image

Cicada Innovations

Cicada Innovations investment in Seed Round - Elastagen

Official Site Inspections

http://www.elastagen.com

  • Host name: ip74001436.ipv4.syd02.ds.network
  • IP address: 116.0.20.54
  • Location: Australia
  • Latitude: -33.494
  • Longitude: 143.2104
  • Timezone: Australia/Sydney

Loading ...

More informations about "Elastagen"

Elastagen - Crunchbase Company Profile & Funding

Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial.See details»

Elastagen - Funding, Financials, Valuation & Investors - Crunchbase

Elastagen provides products that repair and augment skin by using elastin to maintain the skin’s elasticity and supple properties.See details»

Allergan picks up Australian biotech Elastagen in $95M deal

Feb 12, 2018 Dive Brief: Allergan plc will acquire clinical-stage biotech Elastagen Pty Ltd. for $95 million upfront, picking up the Australian company's tissue repair platform in a deal …See details»

Elastagen - Products, Competitors, Financials, Employees, …

Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Use the CB Insights Platform to …See details»

Elastagen - Company Profile - Tracxn

Dec 4, 2024 Elastagen is a clinical stage medical company with a pipeline of formulation products based on the human protein tropoelastin.The company was founded after the …See details»

Elastagen Company Profile 2024: Valuation, Investors ... - PitchBook

Elastagen General Information Description. Operator of a clinical-stage medical company intended to develop human protein tropoelastin-based products that facilitate skin …See details»

Allergan to acquire University of Sydney spinoff Elastagen

Feb 9, 2018 Elastagen Pty Ltd, a clinical stage company developing medical device products based on recombinant tropoelastin, today announced that it has entered into a definitive …See details»

Allergen Acquires Elastagen - Pharma's Almanac

Feb 13, 2018 The botox-maker adds an acne and stretch mark treatment to its portfolio. Allergan plc has agreed to acquire Elastagen Pty Ltd. Elastagen is a clinical stage company that …See details»

Elastagen - Crunchbase

Elastagen provides products that repair and augment skin by using elastin to maintain the skin’s elasticity and supple properties.See details»

Elastagen - Craft

Elastagen is engaged in developing a synthetic version of the elastin protein which is identical to that naturally present in the human body. Its platform technology has potential applications in a …See details»

Allergan to acquire Australian biotech company Elastagen

On 7th February 2018, Elastagen, a clinical-stage Australian company that uses recombinant tropoelastin, has entered into a definitive agreement with Allergan for an upfront payment of …See details»

Elastrin Therapeutics: Reverse Cardiovascular Disease

Elastrin Therapeutics platform technology a solution to heart disease, stroke, high blood pressure, copd and aneurysm. These diseases can be cured by our treatment; a nanoparticle that …See details»

Allergan to Acquire Elastagenu000b to Access Next Generation ...

Feb 7, 2018 Wound Filler Market Insights - Global Analysis and Forecast by 2023:- Get Free Samples@ https://bit.ly/2Xx5Aj9 The 'Global and Chinese Wound Filler Industry, 2013-2023 …See details»

Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

Feb 7, 2018 BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals …See details»

University of Sydney spin-off Elastagen sold for $120m to Botox …

Feb 8, 2018 Allergan, the multinational that makes Botox just paid $120 million for a skin repair treatment from Sydney University's biochemistry lab.See details»

Allergan to Acquire Elastagen to Access Next Generation Injectable ...

Feb 6, 2018 • Clinical stage tropoelastin platform with potential applications in aesthetics, scar remodeling and surgical wound repair • Introduces key ‘youth protein’ tropoelastin to Allergan’s ...See details»

Sydney biotech Elastagen has just been bought for $120 million by …

Feb 14, 2018 A library of influence, inspiring and connecting people through knowledge, storytelling and creativity.See details»

Elastagen - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Elastagen provides products that repair and augment skin by using elastin to maintain the skin’s elasticity and supple properties.See details»

Elastagen (@elastagen) / X

The latest posts from @elastagenSee details»

Elastrin Therapeutics - Crunchbase Company Profile & Funding

Nanoparticle Therapy: A treatment that uses nanoparticles conjugated with antibodies to target and deliver active agents to damaged elastin in tissues, aiming to restore elasticity in blood …See details»

linkstock.net © 2022. All rights reserved